T. Nakai

发表

A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice.

N. Fairweather, R. Tierney, P. Caposio, 2012, Vaccine.

ASP2397 Is a Novel Natural Compound That Exhibits Rapid and Potent Fungicidal Activity against Aspergillus Species through a Specific Transporter

Kiyomitsu Katsumata, S. Matsumoto, Shinobu Takeda, 2019, Antimicrobial Agents and Chemotherapy.

Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Pulmonary Aspergillosis

F. Ikeda, T. Goto, S. Matsumoto, 2000, Antimicrobial Agents and Chemotherapy.

Electron microscopic findings for micafungin-treated experimental pulmonary aspergillosis in mice.

F. Ikeda, K. Shibuya, K. Hatano, 2005, Medical mycology.

In vitro Activity of FK463, a Novel Lipopeptide Antifungal Agent, against a Variety of Clinically Important Molds

K. Nishimura, M. Miyaji, F. Ikeda, 2002, Chemotherapy.

Synthesis and antifungal activity of ASP9726, a novel echinocandin with potent Aspergillus hyphal growth inhibition.

Toru Nakai, Hiroshi Morikawa, Takanobu Araki, 2014, Bioorganic & medicinal chemistry letters.

Novel Carbapenem Antibiotics for Parenteral and Oral Applications: In Vitro and In Vivo Activities of 2-Aryl Carbapenems and Their Pharmacokinetics in Laboratory Animals

Y. Ueda, S. Terashita, K. Takemoto, 2012, Antimicrobial Agents and Chemotherapy.

Killing Activity of Micafungin against Aspergillus fumigatus Hyphae Assessed by Specific Fluorescent Staining for Cell Viability

F. Ikeda, S. Matsumoto, K. Hatano, 2003, Antimicrobial Agents and Chemotherapy.

Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus.

F. Ikeda, K. Hatano, T. Nakai, 2002, The Journal of antibiotics.

In Vitro Antifungal Activity of Micafungin (FK463) against Dimorphic Fungi: Comparison of Yeast-Like and Mycelial Forms

K. Nishimura, M. Miyaji, F. Ikeda, 2003, Antimicrobial Agents and Chemotherapy.

In vitro infection of fractionated chicken lymphocytes by infectious bursal disease virus.

K. Hirai, T. Nakai, 1981, Avian diseases.

Sequential changes in the number of surface immunoglobulin-bearing B lymphocytes in infectious bursal disease virus-infected chickens.

K. Hirai, S. Shimakura, T. Nakai, 1981, Avian diseases.

In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa

F. Ikeda, Y. Wakai, K. Hatano, 2006, Antimicrobial Agents and Chemotherapy.

In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa (cid:1)

F. Ikeda, Y. Wakai, K. Hatano, 2007 .

Overproduction of a Metallo-β-Lactamase by a Strong Promoter Causes High-Level Imipenem Resistance in a Clinical Isolate of Pseudomonas aeruginosa

F. Ikeda, K. Hatano, Shinobu Takeda, 2008, Chemotherapy.